S100A9 and neoplasm: The expression of both Calprotectin subunits S100A8 and S100A9 was examined in clinical PeCa specimens using three TMAs reflecting the tumor center (TMA TC, n = 63), the invasion front (TMA IF, n = 57), and the corresponding lymph node metastases (TMA LM, n = 22).